145 related articles for article (PubMed ID: 7793180)
1. Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis.
Jensen FS; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1995 Feb; 39(2):157-62. PubMed ID: 7793180
[TBL] [Abstract][Full Text] [Related]
2. Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years' experience with the Danish Cholinesterase Research Unit.
Jensen FS; Viby-Mogensen J
Acta Anaesthesiol Scand; 1995 Feb; 39(2):150-6. PubMed ID: 7793179
[TBL] [Abstract][Full Text] [Related]
3. Concordance of butyrylcholinesterase phenotype with genotype: implications for biochemical reporting.
Parnas ML; Procter M; Schwarz MA; Mao R; Grenache DG
Am J Clin Pathol; 2011 Feb; 135(2):271-6. PubMed ID: 21228368
[TBL] [Abstract][Full Text] [Related]
4. An improvement in segregation of human butyrylcholinesterase phenotypes having the fluoride-resistant variants.
Kovarik Z; Simeon-Rudolf V
Arh Hig Rada Toksikol; 2003 Dec; 54(4):239-44. PubMed ID: 14994645
[TBL] [Abstract][Full Text] [Related]
5. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study.
Lando G; Mosca A; Bonora R; Azzario F; Penco S; Marocchi A; Panteghini M; Patrosso MC
Pharmacogenetics; 2003 May; 13(5):265-70. PubMed ID: 12724618
[TBL] [Abstract][Full Text] [Related]
6. An explanation for the different inhibitory characteristics of human serum butyrylcholinesterase phenotypes deriving from inhibition of atypical heterozygotes.
Simeon-Rudolf V; Kovarik Z; Skrinjarić-Spoljar M; Evans RT
Chem Biol Interact; 1999 May; 119-120():159-64. PubMed ID: 10421449
[TBL] [Abstract][Full Text] [Related]
7. Human cholinesterase (pseudocholinesterase): genetic variants and their recognition.
Lehmann H; Liddell J
Br J Anaesth; 1969 Mar; 41(3):235-44. PubMed ID: 5776668
[No Abstract] [Full Text] [Related]
8. Identification of human plasma cholinesterase variants using molecular biological techniques.
Jensen FS; Schwartz M; Viby-Mogensen J
Acta Anaesthesiol Scand; 1995 Feb; 39(2):142-9. PubMed ID: 7793178
[TBL] [Abstract][Full Text] [Related]
9. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
Eskildsen KZ; Gätke MR
Ugeskr Laeger; 2015 Apr; 177(18):866-8. PubMed ID: 26539575
[TBL] [Abstract][Full Text] [Related]
10. [Danish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium].
Eskildsen KZ; Gätke MR
Ugeskr Laeger; 2014 Mar; 176(12A):. PubMed ID: 25350885
[TBL] [Abstract][Full Text] [Related]
11. Prolonged response to succinylcholine: a new variant of plasma cholinesterase that is identified as normal by traditional phenotyping methods.
Greenberg CP; Primo-Parmo SL; Pantuck EJ; la Du BN
Anesth Analg; 1995 Aug; 81(2):419-21. PubMed ID: 7618741
[No Abstract] [Full Text] [Related]
12. Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran.
Vaisi-Raygani A; Rahimi Z; Kharazi H; Tavilani H; Aminiani M; Kiani A; Vaisi-Raygani A; Pourmotabbed T
Clin Biochem; 2007 Jun; 40(9-10):629-33. PubMed ID: 17350607
[TBL] [Abstract][Full Text] [Related]
13. [Butyrylcholinesterase deficiency: how to analyse the cholinesterase activity in small children?].
Lejus C; Delaroche O; Trille E; Blanloeil Y; Pinaud M
Ann Fr Anesth Reanim; 2006 Jun; 25(6):657-60. PubMed ID: 16581221
[TBL] [Abstract][Full Text] [Related]
14. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population.
Yen T; Nightingale BN; Burns JC; Sullivan DR; Stewart PM
Clin Chem; 2003 Aug; 49(8):1297-308. PubMed ID: 12881446
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase: phenotyping and genotyping.
Goodall R;
Ann Clin Biochem; 2004 Mar; 41(Pt 2):98-110. PubMed ID: 15025799
[TBL] [Abstract][Full Text] [Related]
16. Butyrylcholinesterase genes in individuals with abnormal inhibition numbers and with trace activity: one common mutation and two novel silent genes.
Dey DC; Maekawa M; Sudo K; Kanno T
Ann Clin Biochem; 1998 Mar; 35 ( Pt 2)():302-10. PubMed ID: 9547905
[TBL] [Abstract][Full Text] [Related]
17. Activity and polymorphisms of butyrylcholinesterase in a Polish population.
Jasiecki J; Jońca J; Żuk M; Szczoczarz A; Janaszak-Jasiecka A; Lewandowski K; Waleron K; Wasąg B
Chem Biol Interact; 2016 Nov; 259(Pt B):70-77. PubMed ID: 27109752
[TBL] [Abstract][Full Text] [Related]
18. Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations.
Neville LF; Gnatt A; Padan R; Seidman S; Soreq H
J Biol Chem; 1990 Dec; 265(34):20735-8. PubMed ID: 2249982
[TBL] [Abstract][Full Text] [Related]
19. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Gätke MR; Bundgaard JR; Viby-Mogensen J
Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
Delacour H; Lushchekina S; Mabboux I; Ceppa F; Masson P; Schopfer LM; Lockridge O
Biochem Pharmacol; 2014 Dec; 92(3):476-83. PubMed ID: 25264279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
